Galectin-3 And Phagocyte Function In Severe Asthma
Funder
National Health and Medical Research Council
Funding Amount
$698,084.00
Summary
Asthma, a major chronic inflammatory disease affects more than 2 million Australians. Neutrophilic severe asthma is not responsive to current therapies. We have recently made a significant advance in understanding neutrophilic asthma, reporting low levels of a protein called galectin-3 (gal-3). In this project we will explore the role of gal-3 its effect on the resolution of inflammation. This study will result significantly advance the knowledge of the mechanisms of neutrophilic severe asthma.
The Effect Of Chronic Maternal Asthma And Acute Exacerbations On Placental Function And Fetal Development
Funder
National Health and Medical Research Council
Funding Amount
$224,623.00
Summary
Maternal asthma is the most common disease to complicate pregnancies in Australia. The data we have collected so far suggests that asthma represents a physiological maternal stress during pregnancy that influences placental function and fetal development. The purpose of this grant is to continue to determine what changes occur in the presence of maternal asthma that alter fetal growth. The findings of this work will be applicable to any psycho-social or physiological stressor during pregnancy.
Cigaratte Smoke Exposure Suppresses Alveolar Macrophage Responses To Lipopolysaccharide By Modifying The TLR4 Pathway
Funder
National Health and Medical Research Council
Funding Amount
$506,283.00
Summary
Long term cigarette smoke exposure is a major risk factor for cancer, heart disease and emphysema. A less known fact about smoke exposure is that it also leaves people susceptible to respiratory infections by i) physically damaging the lung lining and ii) suppressing cells responsible for coordinating the lungs defence system. This project will identify how smoke exposure blocks the early response to infection by the immune system and discovery novel ways of restoring normal lung defences.
Viral Infection And Exacerbations Of Asthma During Pregnancy: Characteristics, Mechanisms And Consequences
Funder
National Health and Medical Research Council
Funding Amount
$465,210.00
Summary
At least 12% of pregnant women in Australia have asthma and more than half of these women will experience an acute attack during pregnancy. This puts the fetus at risk of poor outcomes such as low birth weight or premature birth, which has a significant impact on their health in both the short term and long term. The mechanisms which lead to exacerbations of asthma during pregnancy are unknown, but have implications for the treatment of pregnant women with asthma. In non-pregnant adults, the maj ....At least 12% of pregnant women in Australia have asthma and more than half of these women will experience an acute attack during pregnancy. This puts the fetus at risk of poor outcomes such as low birth weight or premature birth, which has a significant impact on their health in both the short term and long term. The mechanisms which lead to exacerbations of asthma during pregnancy are unknown, but have implications for the treatment of pregnant women with asthma. In non-pregnant adults, the majority of asthma exacerbations are caused by viral infection and it is likely that a similar mechanism operates in pregnant women with asthma. No previous studies have identified the viruses responsible for exacerbations of asthma during pregnancy. We currently have a promising lead in this area, with data showing that one third of pregnant women with asthma have a severe exacerbation of their asthma requiring medical intervention during pregnancy, and a large proportion of these are likely to be due to viral infection. We propose that during pregnancy, pregnant women with asthma are more susceptible to viral infection than pregnant women without asthma. We also suggest that women with asthma will have more severe viral infections during pregnancy, and that these will contribute to the majority of acute asthma attacks during pregnancy. This project will determine the rate of infection among pregnant women with and without asthma and determine the viruses responsible for acute attacks of asthma during pregnancy. The study will also explore the inflammatory mechanisms which predispose women to viral infection. These results will contribute to a greater understanding of the mechanisms leading to exacerbations of asthma during pregnancy and will be used to develop more appropriate asthma monitoring and treatment strategies for pregnant women, which will have health benefits for both mother and baby.Read moreRead less
The Role Of MicroRNAs As New Anti-inflammatory Targets For The Treatment Of Asthma
Funder
National Health and Medical Research Council
Funding Amount
$625,655.00
Summary
Asthma is a significant health and economic burden to our society and its prevalence has increased over the last 25 years. New ways of treating asthma are urgently required as current therapeutics treat the symptoms and not the cause of the disease. Asthma is widely thought to be due to the abnormal accumulation of white blood cells (inflammation) in the lungs of diseased individuals. In this project we are exploring new advanced ways to inhibit inflammation and the development of disease.
Role Of IL-3 In Allergic Inflammation: Modulation Of Basophils, Mast Cells, Eosinophils And Remodelling In Asthma.
Funder
National Health and Medical Research Council
Funding Amount
$495,380.00
Summary
Asthma is an important disease in the Australian community. We will investigate how the underlying inflammation in this disease is controlled and will focus our studies on a hormone-like regulator of the immune system called interleukin-3. Our hypothesis is that interleukin-3 regulates basophils, mast cells and remodelling of the airways which are central features of asthma. This study will give a better understanding of how the inflammation is caused and information for new drug targets.
The Role Of MicroRNAs In The Regulation Of Antiviral And Inflammatory Responses During Experimental Rhinovirus Infection
Funder
National Health and Medical Research Council
Funding Amount
$605,096.00
Summary
Asthma exacerbations due to viral infections are a major health and economic burden to our society. Treatment of asthma exacerbations focuses on reducing the symptoms rather than the cause of the disease. Virus-induced asthma exacerbation are widely thought to be due to an abnormal influx of white blood cells into the lungs (inflammation) and an altered anti-viral responses. In this project we will explore novel strategies to inhibit inflammation and to promote the anti-viral response.
Asthma is a major health problem for the Australian community. Recent studies have shown increasing numbers of people of all ages are developing asthma. Despite extensive asthma research and the development of new asthma drugs, asthma remains a leading cause of ill- health, especially in children. In many cases the deterioration in asthma symptoms is related to a cold or flu like illness, Viruses are the leading cause of these infections and are known to make asthma symptoms worse. How they do t ....Asthma is a major health problem for the Australian community. Recent studies have shown increasing numbers of people of all ages are developing asthma. Despite extensive asthma research and the development of new asthma drugs, asthma remains a leading cause of ill- health, especially in children. In many cases the deterioration in asthma symptoms is related to a cold or flu like illness, Viruses are the leading cause of these infections and are known to make asthma symptoms worse. How they do this is not completely understood. Asthma causes a unique type of inflammation in the airways, which is present in even mild asthma and can be controlled by medication. Viruses also cause inflammation by infecting the lungs. Viruses can cause severe attacks of asthma even when asthma appears controlled on medication. The ways in which virus infections do this, are not established. By understanding how this happens we may be able to design effective treatment for this problem. Our initial results indicate that virus induced asthma is different to asthma that is triggered by allergens. We plan to investigate what effect certain viruses have on the lungs of people with asthma by measuring cells and chemicals that are present in sputum. We will use recently developed technologies to accurately see what viruses are infecting these people, and then evaluate the role of treatment of virus induced asthma. This study will shed important light on potential causes of unstable asthma and the role that viral infection plays in this. It may also lead to new opportunities to develop treatments that are more effective in preventing and controlling asthma.Read moreRead less
G-CSF: A Pathogenic Effector In Chronic Obstructive Pulmonary Disease And Its Comorbidities
Funder
National Health and Medical Research Council
Funding Amount
$1,241,551.00
Summary
Chronic Obstructive Pulmonary Disease (COPD) is an incurable lung disease that is a huge global health burden, and new therapies are urgently needed. We have recently discovered a possible cause of COPD. This single factor also appears to drive other associated medical problems that are the biggest contributors to patient deterioration. Using advanced genetics, biochemistry and molecular methods we are searching for ways to turn our discovery into effective treatments for this fatal disease.